Korphaisarn, Krittiya
Morris, Van
Davis, Jenifer S.
Overman, Michael J.
Fogelman, David R.
Kee, Bryan K.
Dasari, Arvind
Raghav, Kanwal P. S.
Shureiqi, Imad
Trupti, Metha
Wolff, Robert A.
Eng, Cathy
Menter, David G.
Hamilton, Stanley
Kopetz, Scott
Article History
Received: 11 April 2019
Revised: 16 July 2019
Accepted: 24 July 2019
First Online: 13 August 2019
Competing interests
: The authors declare no competing interests.
: The protocol for this study was approved by The University of Texas MD Anderson Cancer Center Institutional Review Board. All patients provided written informed consent prior to sequencing of their tumours according to the institutional guideline. The study was performed in accordance with the Declaration of Helsinki.
: The University of Texas MD Anderson Cancer Center is supported in part by the National Institutes of Health through Cancer Center Support Grant P30CA016672 and R01CA187238.
: The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request.
: This work is published under the standard license to publish agreement. After 12 months the work will become freely available and the license terms will switch to a Creative Commons Attribution 4.0 International (CC BY 4.0).